Global Custom Market Research Reports Provider Company

Shield Therapeutics Plc (STX) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United Kingdom

Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals for high unmet medical needs. Its product portfolio includes Feraccru, a ferric iron-based oral pharmaceutical product used to treat iron deficiency anaemia (IDA). Shield Therapeutics also provides PT20, an iron-based phosphate binder, developed to treat hyperphosphatemia related to dialysis-dependent or dialysis-independent chronic kidney disease (CKD). The company operates with offices in the UK, Germany and Switzerland. Shield Therapeutics is headquartered in Gateshead, the UK.

Shield Therapeutics Plc Key Recent Developments

Sep 20,2017: Shield Therapeutics: Interim Report for the Six Months Ended 30 June 2017
Sep 14,2017: Shield Therapeutics: Board Change
Apr 04,2017: Shield Therapeutics Announces Preliminary Results for the Year Ended 31 December 2016
Apr 04,2017: Shield Therapeutics Announces Appointment of Chief Financial Officer
Jan 30,2017: Shield Therapeutics: Directorate and Secretarial Update

This comprehensive SWOT profile of Shield Therapeutics Plc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shield Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents

Section 1 - About the Company

Shield Therapeutics Plc - Key Information

Shield Therapeutics Plc - Overview

Shield Therapeutics Plc - Key Employees

Shield Therapeutics Plc - Key Employee Biographies

Shield Therapeutics Plc - Key Operational Heads

Shield Therapeutics Plc - Major Products and Services

Shield Therapeutics Plc - History

Shield Therapeutics Plc - Company Statement

Shield Therapeutics Plc - Locations And Subsidiaries

Shield Therapeutics Plc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Shield Therapeutics Plc - Business Description

Shield Therapeutics Plc - Corporate Strategy

Shield Therapeutics Plc - SWOT Analysis

SWOT Analysis - Overview

Shield Therapeutics Plc - Strengths

Shield Therapeutics Plc - Weaknesses

Shield Therapeutics Plc - Opportunities

Shield Therapeutics Plc - Threats

Shield Therapeutics Plc - Key Competitors

Section 3 - Company Financial Performance Charts

Shield Therapeutics Plc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

Shield Therapeutics Plc, Key Information

Shield Therapeutics Plc, Key Ratios

Shield Therapeutics Plc, Share Data

Shield Therapeutics Plc, Major Products and Services

Shield Therapeutics Plc, History

Shield Therapeutics Plc, Key Employees

Shield Therapeutics Plc, Key Employee Biographies

Shield Therapeutics Plc, Key Operational Heads

Shield Therapeutics Plc, Other Locations

Shield Therapeutics Plc, Subsidiaries

Shield Therapeutics Plc, Key Manufacturing facilities

Shield Therapeutics Plc, Key Competitors

Shield Therapeutics Plc, SWOT Analysis

Shield Therapeutics Plc, Ratios based on current share price

Shield Therapeutics Plc, Annual Ratios

Shield Therapeutics Plc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures

Shield Therapeutics Plc, Performance Chart

Shield Therapeutics Plc, Ratio Charts

In this report, the Asia-Pacific Windshield Washer Fluid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report

In this report, the Asia-Pacific Welding & Shielding Gas market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of

View Report

In this report, the EMEA Front Windshield market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports